Millipore’s Q3 Revenues Rise 38 Percent, Though Serologicals Integration Delays Product Releases | GenomeWeb
Millipore reported a 38-percent spike in third-quarter revenue last week, driven mostly by the addition of Serologicals’ sales, though company officials said that problems consolidating Serologicals caused “near-term disruptions” in shipping products to customers during the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.